SensoDetect appoints Dr Liu as member of SensoDetects medical advisory board
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

SensoDetect appoints Dr Liu as member of SensoDetects medical advisory board

Dr. Liu Hai is a Chief Physician and Associate Professor at Beijing Tiantan Hospital, Capital Medical University. He completed his Ph.D. in 2005 under the supervision of Academician Wang Zhongcheng and has international experience in spinal cord injury research from his time at the University of Rochester and the University of Washington.

Currently, he is a key member of the Office of Scientific and Technological Achievements Transformation at Beijing Tiantan Hospital. Dr. Liu holds several prominent professional affiliations, including committee roles with the Chinese Medical Association, the World Chinese Neurosurgical Society, and the Chinese Rehabilitation Medicine Association, among others.

His research primarily focuses on spinal cord injury, with over 10 SCI-indexed publications. Clinically, he specializes in spinal cord and column tumor treatments, trauma, congenital disorders, and pediatric CNS diseases. Dr. Liu is also leading efforts in translational clinical research and rehabilitation robotics in collaboration with Japanese experts. He has also received numerous competitive research grants and is a reviewer for several international medical journals.

"By welcoming Dr. Liu to our medical advisory board, we gain direct access to the expertise of one of China’s most respected and renowned neurosurgeons. Additionally, his presence strengthens our connections with government officials and the rapidly growing Chinese healthcare market. With Dr. Liu’s support, SensoDetect becomes a strong contender for mental health screening in the largest mental health care initiative in China’s history.” – says CEO Per-Anders (PA) Hedin.

Nyheter om SensoDetect

Läses av andra just nu

Om aktien SensoDetect

Senaste nytt